Stopped Screening was stopped by the Sponsor (43/48 participants enrolled), given the very low number of eligible patients (high vaccination rate and occurrence of the Omicron variant). The last patient randomized performed his follow-up visit.
Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec